Frederik König
Dr. med.
Frederik König
  • Oberarzt
  • Facharzt für Urologie
Arbeitsbereich

Standort

Hauptgebäude O10 , 2. Etage
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Publikationen

Zurück
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
Vor

P084 - Delineating functional outcomes and patient-reported treatment satisfaction after perineal urethrostomy as last resort management of complex anterior urethral strictures: Abstracts EAU24 - 39th Annual EAU Congress
Klemm J, Dahlem R, König F, Shariat S, Marks P, Fisch M, Vetterlein M
EUR UROL. 2024;85(S1):S109-S110.

P082 - Short-term morbidity and long-term functional outcomes of the T-plasty for salvage reconstruction of recalcitrant bladder neck stenosis: Abstracts EAU24 - 39th Annual EAU Congress
König F, Dahlem R, Marks P, Kühnke L, Klemm J, Fisch M, Vetterlein M
EUR UROL. 2024;85(1):S107.

Advancing Intraoperative Assessment of Urethral Stricture Anatomic Variation: a Prospective Proof-of-concept Study
Marks P, Dahlem R, Daniels P, Klemm J, Kühnke L, Kranzbühler B, König F, Ding L, Engel O, Soave A, Fisch M, Vetterlein M
UROL INT. 2024;108(3):254-258.

P175 - What do patients with Peyronie’s disease expect from therapy? A prospective multi-center study: Abstracts EAU24 - 39th Annual EAU Congress
Schaefer L, Cremers J, Witschel B, Schuettfort V, Nieder T, Koenig F, Vetterlein M, Gild P, Dahlem R, Fisch M, Kliesch S, Soave A
EUR UROL. 2024;85(S1):S247.

What do patients with Peyronie's disease expect from therapy?: A prospective multi-center study
Schäfer L, Cremers J, Witschel B, Schüttfort V, Nieder T, König F, Vetterlein M, Gild P, Dahlem R, Fisch M, Kliesch S, Soave A
ANDROLOGY-US. 2024;12(4):821-829.

Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices to Improve the Prediction of Perioperative Morbidity and Long-Term Survival Outcomes After Radical Cystectomy
von Deimling M, Rink M, Klemm J, Koelker M, Schuettfort V, König F, Gild P, Ludwig T, Marks P, Dahlem R, Fisch M, Shariat S, Vetterlein M
CLIN GENITOURIN CANC. 2024;22(2):336-346.e9.

Mucomucosal anastomotic non-transecting augmentation (MANTA) urethroplasty: a ventral modification for obliterative strictures
Marks P, Dahlem R, Janisch F, Klemm J, Kühnke L, König F, Ding L, Riechardt S, Fisch M, Vetterlein M
BJU INT. 2023;132(4):444-451.

Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients - A Multicenter, Retrospective, Observational Study
Pallauf M, D'Andrea D, König F, Laukthina E, Yanagisawa T, Rouprêt M, Daneshmand S, Djaladat H, Ghoreifi A, Soria F, Fujita K, Boorjian S, Potretzke A, Mari A, Roumiguié M, Antonelli A, Bianchi A, Khene Z, Sfakianos J, Jamil M, Boormans J, Raman J, Grossmann N, Breda A, Heidenreich A, Del Giudice F, Singla N, Shariat S, Pradere B
J UROLOGY. 2023;209(3):515-524.

Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy
von Deimling M, Rink M, Klemm J, Koelker M, König F, Gild P, Khonsari M, Ludwig T, Marks P, Dahlem R, Fisch M, Vetterlein M
BJU INT. 2023;131(1):90-100.

Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis
Yanagisawa T, Kawada T, Rajwa P, Mostafaei H, Motlagh R, Quhal F, Laukhtina E, König F, Pallauf M, Pradere B, Karakiewicz P, Nyirady P, Kimura T, Egawa S, Shariat S
UROL ONCOL-SEMIN ORI. 2023;41(4):177-191.

Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta-analysis
Yanagisawa T, Mori K, Quhal F, Kawada T, Mostafaei H, Laukhtina E, Rajwa P, Sari Motlagh R, Aydh A, König F, Pallauf M, Pradere B, Miki J, Kimura T, Egawa S, Shariat S
BJU INT. 2023;131(5):540-552.

Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
Grossmann N, Rajwa P, Quhal F, König F, Mostafaei H, Laukhtina E, Mori K, Katayama S, Motlagh R, Fankhauser C, Mattei A, Moschini M, Chlosta P, van Rhijn B, Teoh J, Compérat E, Babjuk M, Abufaraj M, Karakiewicz P, Shariat S, Pradere B
EUR UROL OPEN SCI. 2022;39:14-21.

Comparison of short-term and long-term neoadjuvant hormone therapy prior to radical prostatectomy: a systematic review and meta-analysis
Katayama S, Mori K, Pradere B, Mostafaei H, Schuettfort V, Quhal F, Motlagh R, Laukhtina E, Grossmann N, Rajwa P, Aydh A, König F, Mathieu R, Nyirady P, Karakiewicz P, Nasu Y, Shariat S
SCAND J UROL. 2022;56(2):85-93.

Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis
Katayama S, Mori K, Pradere B, Yanagisawa T, Mostafaei H, Quhal F, Motlagh R, Laukhtina E, Grossmann N, Rajwa P, Aydh A, König F, Karakiewicz P, Araki M, Nasu Y, Shariat S
J ROBOT SURG. 2022;16(6):1233-1247.

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Katayama S, Schuettfort V, Pradere B, Mori K, Mostafaei H, Quhal F, Sari Motlagh R, Laukhtina E, Grossmann N, Aydh A, Rajwa P, König F, Karakiewicz P, Haydter M, Moschini M, Abufaraj M, Lotan Y, Lee R, Trinh Q, Compérat E, Teoh J, Nasu Y, Shariat S
J CANCER RES CLIN. 2022;148(11):3091-3102.

Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer:A Systematic Review and Meta-analysis
Kawada T, Yanagisawa T, Rajwa P, Sari Motlagh R, Mostafaei H, Quhal F, Laukhtina E, Aydh A, König F, Pallauf M, Pradere B, Ceci F, Baltzer P, Hacker M, Rasul S, Karakiewicz P, Araki M, Nasu Y, Shariat S
EUR UROL ONCOL. 2022;5(4):390-400.

Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics
König F, Grossmann N, Soria F, D'Andrea D, Juvet T, Potretzke A, Djaladat H, Ghoreifi A, Kikuchi E, Hayakawa N, Mari A, Khene Z, Fujita K, Raman J, Breda A, Fontana M, Sfakianos J, Pfail J, Laukhtina E, Rajwa P, Pallauf M, Cacciamani G, van Doeveren T, Boormans J, Antonelli A, Jamil M, Abdollah F, Budzyn J, Ploussard G, Heidenreich A, Daneshmand S, Boorjian S, Rouprêt M, Rink M, Shariat S, Pradere B
CANCERS. 2022;14(7):.

Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review
König F, Pradere B, Grossmann N, Quhal F, Rajwa P, Laukhtina E, Mori K, Katayama S, Yanagisawa T, Mostafai H, Motlagh R, Aydh A, Dahlem R, Shariat S, Rink M
TRANSL CANCER RES. 2022;11(4):908-917.

Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study
Laukhtina E, Boehm A, Peyronnet B, Bravi C, Batista Da Costa J, Soria F, D'Andrea D, Rajwa P, Quhal F, Yanagisawa T, König F, Mostafaei H, Enikeev D, Ingels A, Verhoest G, D'Hondt F, Mottrie A, Joniau S, Van Poppel H, de la Taille A, Bensalah K, Bruyère F, Shariat S, Pradere B
WORLD J UROL. 2022;40(7):1689-1696.

Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma
Laukhtina E, Hassler M, Pradere B, Yanagisawa T, Quhal F, Rajwa P, Sari Motlagh R, König F, Pallauf M, Kawada T, Mostafaei H, D'Andrea D, Enikeev D, Shariat S
EUR UROL FOCUS. 2022;8(6):1683-1686.

Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy
Laukhtina E, Quhal F, Mori K, Sari Motlagh R, Rajwa P, Yanagisawa T, Mostafaei H, König F, Aydh A, Pradere B, Enikeev D, Karakiewicz P, Schmidinger M, Shariat S
EUR UROL ONCOL. 2022;5(1):120-124.

The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy
Mori K, Schuettfort V, Katayama S, Laukhtina E, Pradere B, Quhal F, Sari Motlagh R, Mostafaei H, Grossmann N, Rajwa P, König F, Aydh A, Soria F, Moschini M, Karakiewicz P, Lotan Y, Scherr D, Haydter M, Nyirady P, Teoh J, Egawa S, Compérat E, Shariat S
EUR UROL FOCUS. 2022;8(4):972-979.

Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis
Mostafaei H, Salehi-Pourmehr H, Jilch S, Carlin G, Mori K, Quhal F, Pradere B, Grossmann N, Laukhtina E, Schuettfort V, Aydh A, Sari Motlagh R, König F, Roehrborn C, Katayama S, Rajwa P, Hajebrahimi S, Shariat S
EUR UROL FOCUS. 2022;8(4):1072-1089.

A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery
Pallauf M, König F, D'Andrea D, Laukhtina E, Mostafaei H, Motlagh R, Quhal F, Aydh A, Yanagisawa T, Kawada T, Rajwa P, Lusuardi L, Soria F, Karakiewicz P, Rouprêt M, Rink M, Lotan Y, Margulis V, Singla N, Xylinas E, Shariat S, Pradere B
FRONT ONCOL. 2022;12:.

Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis and Network Meta-Analysis with Focus on Different Energy Sources
Sari Motlagh R, Rajwa P, Mori K, Laukhtina E, Aydh A, Katayama S, Yanagisawa T, König F, Grossmann N, Pradere B, Mostafai H, Quhal F, Karakiewicz P, Babjuk M, Shariat S
J ENDOUROL. 2022;36(4):535-547.

Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis
Sari Motlagh R, Yanagisawa T, Kawada T, Laukhtina E, Rajwa P, Aydh A, König F, Pallauf M, Huebner N, Baltzer P, Karakiewicz P, Heidenreich A, Shariat S
PROSTATE CANCER P D. 2022;25(2):187-198.

A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma
Schuettfort V, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, König F, Rink M, Abufaraj M, Karakiewicz P, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann N, Katayama S, Pradere B, Shariat S
BJU INT. 2022;129(2):182-193.

Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis
Yanagisawa T, Mori K, Katayama S, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Motlagh R, Aydh A, König F, Grossmann N, Pradere B, Miki J, Kimura T, Egawa S, Shariat S
INT J CLIN ONCOL. 2022;27(1):59-71.

Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis
Yanagisawa T, Mori K, Katayama S, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Motlagh R, Aydh A, König F, Grossmann N, Pradere B, Miki J, Schmidinger M, Egawa S, Shariat S
IMMUNOTHERAPY-UK. 2022;14(9):709-725.

Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis
Yanagisawa T, Mori K, Kawada T, Motlagh R, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Aydh A, König F, Pallauf M, Pradere B, Miki J, Kimura T, Egawa S, Shariat S
UROL ONCOL-SEMIN ORI. 2022;40(7):315-330.

En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology
Yanagisawa T, Mori K, Motlagh R, Kawada T, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Aydh A, König F, Pallauf M, Pradere B, D'Andrea D, Compérat E, Miki J, Kimura T, Egawa S, Shariat S
J UROLOGY. 2022;207(4):754-768.

Quality indicators for the management of high-risk upper tract urothelial carcinoma requiring radical nephroureterectomy
König F, Shariat S, Karakiewicz P, Mun D, Rink M, Pradere B
CURR OPIN UROL. 2021;31(4):291-296.

"Dos und Don'ts" bei Hypogonadismus
König F, Soave A
Uro-News. 2021;25:20–25.

Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes
Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann N, König F, Aydh A, Pradere B, Resch I, Merseburger A, Enikeev D, Shariat S
CRIT REV ONCOL HEMAT. 2021;169:.

The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer
Quhal F, Rajwa P, Mori K, Laukhtina E, Grossmann N, Schuettfort V, König F, Aydh A, Motlagh R, Katayama S, Mostafai H, Pradere B, Marra G, Gontero P, Mathieu R, Karakiewicz P, Briganti A, Shariat S, Heidenreich A
PROSTATE. 2021;81(11):765-771.

Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy
Rajwa P, Huebner N, Hostermann D, Grossmann N, Schuettfort V, Korn S, Quhal F, König F, Mostafaei H, Laukhtina E, Mori K, Motlagh R, Yanagisawa T, Aydh A, Bryniarski P, Pradere B, Paradysz A, Baltzer P, Grubmüller B, Shariat S
J PERS MED. 2021;11(11):.

Induratio penis plastica: Herausforderungen der somatischen Therapie und Unterstützungsmöglichkeiten durch Psychotherapie
Soave A, König F, Dahlem R, Rink M, Riechardt S, Fisch M, Briken P, Nieder T
Z SEXUALFORSCH. 2021;34(4):208-218.

Longitudinal Evaluation of Perineogenital Pain and Postoperative Complications After One-stage Buccal Mucosal Graft Urethroplasty: A Secondary Analysis of a Randomized Controlled Trial
Fuehner C, Vetterlein M, Lesske J, Rink M, Riechardt S, König F, Gild P, Pinnschmidt H, Meyer C, Ludwig T, Engel O, Fisch M, Dahlem R, Soave A
EUR UROL FOCUS. 2020;7(5):1157-1165.

First Report of a Symptomatic Calculus of the Ampulla of the Ductus Deferens
Wiesmayr M, Meyer D, König F, Engeler D, Schmid H, Müllhaupt G
Journal of endourology case reports. 2020;6(4):253-255.

Letzte Aktualisierung aus dem FIS: 02.12.2024 - 23:34 Uhr